Azerbaijan summary indicators
| Baseline costing indicators | 2001 |
| GDP per capita1 | $643 |
| Population2 | $8,198,174 |
| Surviving infants2 | 123,285 |
| DTP-3 coverage3 | 98% |
| Total health expenditure per capita (current $)4 | $27.2 |
| Total spending on routine immunization5 | $0 |
| - per DTP-3 immunized child | $0.0 |
| - per capita | $0.00 |
| - as a % of overall health expenditure | 0.0% |
| Total spending on the NIP (including campaigns)5 | $0 |
| - as a % of overall health expenditure | 0.0% |
| Future resource requirements, financing and gaps5 | 2004-2005 |
| Avg. annual resource requirements | $1,925,442 |
| - % new-underused vaccines | 25.6% |
| - per DTP-3 targeted child | $18.0 |
| Avg. annual secure funding | $1,730,529 |
| - % from government | 74.7% |
| - % from GAVI-Vaccine Fund | 11.2% |
| - % from other donors | 14.2% |
| Avg. annual probable funding | $194,913 |
| Avg. annual funding gap (secure and probable funding) | $0 |
| - % of resource requirements | 0.0% |
| - per DTP-3 targeted child | $0.0 |
Sources:
- World Development Indicators - World Bank for GDP
- United Nations Population Division, Department of Economic and Social Affairs, World Population Prospects the 2002 Revisions
- WHO-UNICEF Coverage Best Estimates
- WHO - World Health Report 2003, 2004 and 2005
- Immunization Financing Database. Immunization specific spending is reported.